Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · June 06, 2023

Radical Cystectomy vs Trimodality Therapy in Patients With Muscle-Invasive Bladder Cancer

The Lancet Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet Oncology
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Lancet Oncol 2023 May 12;[EPub Ahead of Print], AR Zlotta, LK Ballas, A Niemierko, K Lajkosz, C Kuk, G Miranda, M Drumm, A Mari, E Thio, NE Fleshner, GS Kulkarni, MAS Jewett, RG Bristow, C Catton, A Berlin, SS Sridhar, A Schuckman, AS Feldman, M Wszolek, DM Dahl, RJ Lee, PJ Saylor, MD Michaelson, DT Miyamoto, A Zietman, W Shipley, P Chung, S Daneshmand, JA Efstathiou

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading